Front. Microbiol. Frontiers in Microbiology Front. Microbiol. 1664-302X Frontiers Media S.A. 10.3389/fmicb.2025.1646639 Microbiology Correction Correction: Anti-MRSA activities of enterocins DD28 and DD93 and evidences on their role in the inhibition of biofilm formation Al Atya Ahmed K. 1 Belguesmia Yanath 1 Chataigne Gabrielle 1 Ravallec Rozenn 1 Vachée Anne 2 Szunerits Sabine 3 Boukherroub Rabah 3 Drider Djamel 1 * 1Université de Lille 1 Sciences et Technologies - Institut Charles Viollette, Lille, France 2Hôpital Victor Provo de Roubaix, Roubaix, France 3Institut d'Electronique, de Microélectronique et de Nanotechnologie, UMR CNRS 8520, Université Lille 1, Lille, France

Edited and reviewed by: Rustam Aminov, University of Aberdeen, United Kingdom

 *Correspondence: Djamel Drider djamel.drider@univ-lille1.fr 11 08 2025 2025 16 1646639 13 06 2025 28 07 2025 Copyright © 2025 Al Atya, Belguesmia, Chataigne, Ravallec, Vachée, Szunerits, Boukherroub and Drider. 2025 Al Atya, Belguesmia, Chataigne, Ravallec, Vachée, Szunerits, Boukherroub and Drider

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Correction on Anti-MRSA activities of enterocins DD28 and DD93 and evidences on their role in the inhibition of biofilm formation by Al Atya, A. K., Belguesmia, Y., Chataigne, G., Ravallec, R., Vachée, A., Szunerits, S., Boukherroub, R., and Drider, D. (2016). Front. Microbiol. 7:817. doi: 10.3389/fmicb.2016.00817 enterocins antibiotics MRSA synergism bacteriocins section-at-acceptance Antimicrobials, Resistance and Chemotherapy

There was a mistake in Figure 4 as published. A wrong figure appeared.

The corrected Figure 4 and it's caption appear below.

Biofilms formation by MRSA-S1 on AISI 304L stainless steel slides conditioned with antimicrobial agents for 2 h and then washed and inoculated with 2 ml of 107 CFU/ml MRSA-S1 culture before removing, washing and adding TSB-YE medium for 0, 3, 6, and 24 h of incubation at 37°C. Concentrations of antimicrobial agents used were 8 mg/L for erythromycin, 0.03 mg/L for rifampin, 200 mg/L for enterocin DD28, 50 mg/L + 1 mg/L for enterocin DD28 + erythromycin, respectively. Biofilms were stained with the BacLight Live/Dead Viability Kit and imaged by epifluorescence microscopy after staining pattern for live cells (green) and dead cells (red). The experiments were performed at least twice and representative images are shown.

A series of fluorescent microscopy images showing bacterial growth over time with different treatments. The grid shows images at 0, 3, 6, and 24 hours for each treatment: control, erythromycin, ofloxacin, DD28, DD93, erythromycin with DD28, rifampin, and vancomycin. Each row represents a different time point, displaying variations in bacterial growth and fluorescence intensity.

The original version of this article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.